Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conductinnovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

BITS Pilani is a Deemed to be University, offering on-campus programs to more than 17,500 students across its campuses in Pilani, Goa, Hyderabad and Dubai. It has been recognized as an Institute of Eminence by the Ministry of Education, Government of India in 2020. In the NIRF 2022 rankings, BITS Pilani has been ranked 5th in Pharmacy, 18th in the University category and 29th in Engineering. In QS Asia University Rankings 2023, BITS has been ranked 188th, the only private institute from India in Asia Top 200, and at 18 in India.

Indian Institute of Science Education and Research (IISER) Tirupati is a premier autonomous Institution established by the Ministry of Education, Government of India, for promotion of high- quality science education and research in the country. The IISERs represent a unique initiative in India where teaching and education are integrated with state-of-the-art research, nurturing both curiosity and creativity in an intellectually vibrant atmosphere of research. Each IISER is an autonomous institution awarding its own Bachelors, Masters and Doctoral degrees.

Bharat Parenterals Ltd. is a Gujarat based pharmaceutical company, established in 1992 by Mr. Ramesh Desai, who started the company with a vision of making world class affordable medicines and to take it to the forefront of contract manufacturing units in Gujarat.

For the first time, the developmental stages of the deadliest human malaria parasite have been mapped in high resolution, allowing researchers to understand this ever-adapting adversary in more detail than previously possible.

Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times, a hallmark of cancer cells.

The findings, published May 3 in Science, reveal what goes wrong when a group of molecules and enzymes trigger and regulate what’s known as the “cell cycle,” the repetitive process of making new cells out of the cells’ genetic material.